10th Feb 2011 12:12
For immediate release | 10 February 2011 |
3D DIAGNOSTIC IMAGING PLC
("3D" or "the Company")
Director's Dealings - Reorganisation of Share Options
As detailed in the admission document dated 26 October 2010 ("the Admission Document"), the Company has both an unapproved Share Option Scheme and an EMI Share Option Scheme.
As disclosed in the Admission Document, Graham Lay and Oliver Cooke, have options over 8,523,741 and 5,966,618 ordinary shares respectively that had been issued to them under the unapproved Share Option Scheme. The Company was informed on 12 January 2011 that these options have now been cancelled and replaced with options over 1,766,649 and 1,999,983 ordinary shares respectively issued under the EMI Share Option Scheme and with options over 6,757,092 and 3,966,635 ordinary shares respectively issued under the unapproved Share Option Scheme.
As a consequence of this reorganisation there has been no change to the aggregate number, the exercise price, the vesting terms or to the performance criteria of the options held by either Graham Lay or Oliver Cooke.
Following this transaction there is no change to the beneficial holdings of Graham Lay or Oliver Cooke in the Company.
For further information please contact:
3D Diagnostic Imaging Plc | |
Graham Lay, CEO | +44 (0) 1624 679000 |
Oliver Cooke, FD | |
finnCap | NOMAD & Broker |
Geoff Nash Henrik Persson
| +44 (0)20 7600 1658 |
| |
Buchanan Communications | Financial PR |
Diane Stewart Carrie Clement | +44 (0) 207 466 5000 |
Notes to Editors:
CarieScan PROtm
The PROtm is a highly accurate, easy to use, hand held device for the early detection and monitoring of dental caries (tooth decay). The PROtm already has CE Mark and FDA 510K approval for sale in Europe and the USA.
The CarieScan PROtm measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects "hidden" decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.
The lightweight caries detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately 4 seconds per tooth with the result displayed on the CarieScan PROtm.
Related Shares:
Afriag Global